$1.85
0.12 (+6.94%)
Pharmacyclics, Inc. (PCYC)
CAPS Rating:
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.